Research in virology最新文献

筛选
英文 中文
Spontaneous shift of an HSV type 1 productive, persistently infected macrophage-like culture to a non-productive culture HSV 1型产生性、持续感染的巨噬细胞样培养物向非产生性培养物的自发转移
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80032-0
R. Tirado, R.E. Sarmiento, B. Gómez
{"title":"Spontaneous shift of an HSV type 1 productive, persistently infected macrophage-like culture to a non-productive culture","authors":"R. Tirado,&nbsp;R.E. Sarmiento,&nbsp;B. Gómez","doi":"10.1016/S0923-2516(98)80032-0","DOIUrl":"10.1016/S0923-2516(98)80032-0","url":null,"abstract":"<div><p>A herpes simplex virus type 1 (HSV1) productive, persistently infected murine macrophage-like culture was obtained by infection at low multiplicity (0.001). Persistent cultures were characterized by spontaneously ceasing to produce infectious viruses after initial HSV1 production. A similar pattern of virus production was observed in cultures obtained by reinfection of the persistent macrophages with the original virus. Nonetheless, in persistent and reinfected cultures (17/18) which did not produce infectious viruses, viral proteins were detected by immunoblot, although their molecular weight, number and pattern differed among the cultures.</p></div><div><p>Une culture de cellules murines ≪ macrophagelike ≫ infectée par un virus herpes simplex de type 1 a été obtenue par infection à basse multiplicité. Des cultures persistantes se caractérisent en cessant de produire des virus infectieux. Un modèle semblable de production virale est observé dans des cultures obtenues par réinfection des macrophages persistants par le virus original. Toutefois, dans des cultures persistantes et réinfectées qui n'ont pas produit de virus infectieux, des protéines virales ont été détectées par ≪ immunoblots ≫ mais leur poids moléculaire, leur nombre et leur profil diffèrent d'une culture à l'autre.</p></div>","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Pages 145-151"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80032-0","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20627658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Infection of WHV/c-myc transgenic mice with Moloney murine leukaemia virus and proviral insertion near the syndecan-4 gene in an early liver tumour Moloney小鼠白血病病毒感染WHV/c-myc转基因小鼠及早期肝肿瘤中syndecan-4基因附近的前病毒插入
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80031-9
C.-A. Renard, C. Transy, P. Tiollais, M.A. Buendia
{"title":"Infection of WHV/c-myc transgenic mice with Moloney murine leukaemia virus and proviral insertion near the syndecan-4 gene in an early liver tumour","authors":"C.-A. Renard,&nbsp;C. Transy,&nbsp;P. Tiollais,&nbsp;M.A. Buendia","doi":"10.1016/S0923-2516(98)80031-9","DOIUrl":"10.1016/S0923-2516(98)80031-9","url":null,"abstract":"<div><p>The capacity of Moloney murine leukaemia virus (MoMLV) to infect neonatal hepatocytes and to accelerate liver carcinogenesis was examined in a transgenic mouse model. WHV/c-<em>myc</em> mice which are highly susceptible to the development of liver tumours were infected with MoMLV shortly after birth, when expression of the murine ecotropic retroviral receptor gene was still detectable in the neonatal liver. All MoMLVinfected transgenic mice and non-transgenic littermates succumbed to T-cell lymphomas within 2–9 months; during this period of time, three infected transgenic animals developed primary hepatocellular carcinomas. Remarkably, one of these liver tumours arose significantly faster than tumours from uninfected WHV/c-<em>myc</em> controls, and it harboured a unique MoMLV provirus. The provirus integration site was located 5.5 kb upstream of the first exon of the syndecan-4 gene, which encodes a heparan sulphate proteoglycan implicated in growth factor activation and protein kinase C distribution in focal adhesions. Our data provide evidence for clonal MoMLV provirus integration in a hepatocellular carcinoma, and indicate that parenchymal liver cells may be susceptible to MoMLV infection following neonatal inoculation.</p></div><div><p>Nous avons cherché à determiner si le virus de la leucémie murine de Moloney (MoMLV) pouvait infecter les hépatocytes murins après inoculation de souris transgéniques à la naissance et s'il pouvait accélérer la carcinogenése hépatique. Les souris WHV/c-<em>myc</em> fortement prédisposées au développement du cancer primitif du foie et des souris non transgéniques témoins ont été infectées par MoMLV 24 h aprés la naissance. L'expression du gène codant le récepteur des rétrovirus murins écotropes est encore détectable dans le foie néonatal. Toutes les souris infectées, transgéniques et non transgéniques ont développé des lymphomes T en 2 à 9 mois. Pendant cette période, 3 souris WHV/c-<em>myc</em> ont développé des carcinomes hépatocellulaires; l'une de ces tumeurs est apparue beau-coup plus rapidement que les tumeurs des souris WHV/c-<em>myc</em> non infectées. Dans ce cas, nous avons mis en évidence une intégration unique et clonale d'un provirus MoMLV, dont le site est localisé à une distance de 5,5 kb du premier exon du gène syndecan-4. Les syndecans sont des composants des adhésions focales appartenant à la famille des protéoglycans, qui jouent un rôle dans l'activation de facteurs de croissance et de la protéine kinase C. Nos données montrant l'insertion d'ADN proviral dans un carcinome hépatocellulaire indiquent que le virus MoMLV est capable d'infecter les hépatocytes après inoculation des animaux à la naissance.</p></div>","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Pages 133-143"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80031-9","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20627657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis 在乙型肝炎病毒a组抗原诱导保护中,至少有三个表位被人类库识别;对血清预防和血清诊断可能产生的后果
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80033-2
P. Maillard , J. Pillot
{"title":"At least three epitopes are recognized by the human repertoire in the hepatitis B virus group a antigen inducing protection; possible consequences for seroprevention and serodiagnosis","authors":"P. Maillard ,&nbsp;J. Pillot","doi":"10.1016/S0923-2516(98)80033-2","DOIUrl":"10.1016/S0923-2516(98)80033-2","url":null,"abstract":"&lt;div&gt;&lt;p&gt;Many recent investigations have shown that both HBV and anti-HBs antibodies coexist in the same patient, and HBV can be found in individuals with anti-HBc antibodies in the absence of immunologically detectable HBsAg. In most cases, mutant forms of HBV affecting the region of the envelope gene coding for the group &lt;em&gt;a&lt;/em&gt; determinant recognized by human antibodies have been found.&lt;/p&gt;&lt;p&gt;The nature of the group &lt;em&gt;a&lt;/em&gt; determinant was revisited with an ELISA involving dissociated, but not alkylated, envelope subunits. No antibody recognizing a continuous epitope of the major S envelope protein could be found in humans; the full activity of human anti-HBs antibodies appeared to be focused on the discontinuous group &lt;em&gt;a&lt;/em&gt; determinant. The immunological human repertoire against the HBsAg group &lt;em&gt;a&lt;/em&gt; determinant was analysed by competitive inhibition of three mouse monoclonal antibodies (mAbs) selected as recognizing three distinct specificities on the group &lt;em&gt;a&lt;/em&gt; determinant. Antibodies to specificities #1 and 3 were found in 52/70 anti-HBs human sera and generally predominated over specificity #2, which was lacking in some sera. The heterogeneity of the group a determinant suggested by these data argue for the use of more than one type of anti-HBs mAb for seroprevention of recurrence after liver transplantation and HBs serodiagnosis. Provided all three types of mAbs characterized here recognize HBV variants with mutations in the a determinant and are virus-neutralizing, it may be helpful, after association of such mAbs, to use them for diagnosis and to devise new immunotherapeutic strategies to prevent emergence of HBsAg escape mutants.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;De nombreuses investigations montrent que la presence concomitante du virus de l'hépatite B (VHB) et d'anticorps anti-HBs n'est pas rare chez un même patient. Dans la majorité des cas, des mutants du VHB avec des substitutions de bases affectant la région codant l'antigène conformationnel de groupe &lt;em&gt;a&lt;/em&gt; inducteur de la protection, ont été observées.&lt;/p&gt;&lt;p&gt;La nature de l'antigène de groupe &lt;em&gt;a&lt;/em&gt; a été réétudiée avec un test ELISA mettant en jeu les sous-unités dissociées, et pour la première fois non alkylées, de l'enveloppe virale. Aucun anticorps reconnaissant un épitope continu de la region S de l'enveloppe n'a pu être mis en évidence chez l'homme; toute l'activité des serums humains anti-HBs paraît focalisée sur l'antigène de groupe &lt;em&gt;a&lt;/em&gt;.&lt;/p&gt;&lt;p&gt;Le répertoire immunologique de l'homme vis-à-vis de cet antigène a été analysé par inhibition compétitive avec trois anticorps monoclonaux de souris sélectionnés parce que reconnaissant trois spécificités distinctes au sein du déterminant de groupe &lt;em&gt;a&lt;/em&gt; de l'enveloppe virale. Les spécificitiés anticorps n&lt;sup&gt;o&lt;/sup&gt; 1 et n&lt;sup&gt;o&lt;/sup&gt; 3 sont présentes dans 52/70 sérums anti-HBs et prédominent généralement sur la spécificité n&lt;sup&gt;o&lt;/sup&gt; 2 qui faisait défaut dans quelques sérums. Aucune différence n'a pu ","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Pages 153-161"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80033-2","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20626370","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 11
Jaroszelski, M.J.和Heller, R. -流式细胞术方案,《分子生物学方法》第91卷。胡玛纳出版社。
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80038-1
P. Métézeau
{"title":"","authors":"P. Métézeau","doi":"10.1016/S0923-2516(98)80038-1","DOIUrl":"10.1016/S0923-2516(98)80038-1","url":null,"abstract":"","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Page 188"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80038-1","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56192690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lassner, D., Pustowoit, B. & Rolfs, A. - DNA扩增技术的现代应用,问题和新工具。充气出版社。
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80036-8
J.-L. Guesdon
{"title":"","authors":"J.-L. Guesdon","doi":"10.1016/S0923-2516(98)80036-8","DOIUrl":"10.1016/S0923-2516(98)80036-8","url":null,"abstract":"","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Page 187"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80036-8","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56192668","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
-差异显示逆转录pcr技术(DDRT-PCR)。斯普林格出版社。
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80037-X
J.-L. Guesdon
{"title":"","authors":"J.-L. Guesdon","doi":"10.1016/S0923-2516(98)80037-X","DOIUrl":"10.1016/S0923-2516(98)80037-X","url":null,"abstract":"","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Pages 187-188"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80037-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56192678","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
传染病的分子诊断:方法和方案。人类出版社。
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80039-3
P. Sansonetti
{"title":"","authors":"P. Sansonetti","doi":"10.1016/S0923-2516(98)80039-3","DOIUrl":"10.1016/S0923-2516(98)80039-3","url":null,"abstract":"","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Page 188"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80039-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"56192703","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rearrangements of archetypal regulatory regions in JC virus genomes from urine 尿中JC病毒基因组原型调控区的重排
Research in virology Pub Date : 1998-05-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80034-4
H.T. Agostini , C.F. Ryschkewitsch, G.L. Stoner
{"title":"Rearrangements of archetypal regulatory regions in JC virus genomes from urine","authors":"H.T. Agostini ,&nbsp;C.F. Ryschkewitsch,&nbsp;G.L. Stoner","doi":"10.1016/S0923-2516(98)80034-4","DOIUrl":"10.1016/S0923-2516(98)80034-4","url":null,"abstract":"<div><p>The regulatory region of progressive multifocal leukoencephalopathy-type JC virus (JCV) is rearranged in each host by a process of deletion and duplication. Of the more than 40 that have been examined, no two regulatory regions have been rearranged identically in the brain. The substrate for this rearrangement appears to be a highly stable archetypal regulatory region excreted in the urine. Its role as the transmissible form of the virus, although inferred, has never been proven. We have now amplified by PCR and cycle-sequenced the regulatory regions from 48 urinary strains of the virus. We find that the urinary form of the regulatory region is not entirely stable. Short deletions and duplications in the range of 2-16 bp were observed in seven of these strains. One of these, an inverted repeat, is a pattern of rearrangement not yet found in the brain. Two others (#208 and 230) showed a 2-bp deletion at position nos. 221 and 222, and an unusual mutation at position no. 219. These two urines were collected in different states of the USA at different times and analysed months apart. It is very unlikely that these unusual changes represent sample contamination or that they arose independently. This finding indicates that archetypal forms of the JCV regulatory region are infectious, despite their relative inactivity in tissue culture. While changes in the archetypal structure can be found, it is clear that rearrangements in the kidney are rare or rarely infectious.</p></div><div><p>La région régulatrice du virus JC (JCV) de type PML (leucoencephalopathie multifocale progressive) est réarrangee chez l'hôte par un processus de délétion et de duplication. Dans le cerveau, on n'observe aucun réarrangement identique entre les régions régulatrices étudiées. Le substrat des réarrangements est une région régulatrice archétypique très stable, excrétée dans les urines. Son rôle en tant que forme transmissible du virus n'a jamais été démontré. Nous avons amplifié (PCR) et séquencé les regions regulatrices de 48 souches virales urinaires et noté que la forme urinaire de ces régions n'est pas tout à fait stable. Pour 7 souches on observe des courtes délétions et des duplications de 2 à 16 pb. Dans 1 cas on note un profil de rearrangement non observé dans le cerveau. Pour 2 autres souches (no. 208 et no. 230) on note une délétion de 2 pb dans les positions 221 et 222 et une mutation en position 219; ces échantillons d'urines ont été collectés aux USA et analysés à des moments différents. Il est peu probable que ces modifications inhabituelles soient des contaminations d'échantillons et qu'elles se soient manifestées indépendamment. Ces résultats montrent que les formes archétypiques de la région régulatrice du JCV sont infectieuses, en dépit de leur inactivité relative en culture de tissu. Des réarrangements dans le rein sont rares et rarement infectieux.</p></div>","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 3","pages":"Pages 163-170"},"PeriodicalIF":0.0,"publicationDate":"1998-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80034-4","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20627661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
HNF1 is critical for the liver-specific function of HBV enhancer II HNF1对HBV增强子II的肝脏特异性功能至关重要
Research in virology Pub Date : 1998-03-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80085-X
W.X. Wang, M. Li, X. Wu, Y. Wang, Z.P. Li
{"title":"HNF1 is critical for the liver-specific function of HBV enhancer II","authors":"W.X. Wang,&nbsp;M. Li,&nbsp;X. Wu,&nbsp;Y. Wang,&nbsp;Z.P. Li","doi":"10.1016/S0923-2516(98)80085-X","DOIUrl":"10.1016/S0923-2516(98)80085-X","url":null,"abstract":"<div><p>Hepatitis B virus (HBV) is a hepatotropic virus and its gene expression is highly liverspecific. It has been reported that the function of enhancer II (ENII) and the core promoter (Cp) of HBV has a hepatocyte preference. To understand the effects of liver-specific nuclear factors on ENII, in this report, hepatocyte nuclear factor 1 (HNF1) was investigated for its possible action on ENII function. It was found that HNF1 transactivates ENII/Cp in HeLa cells, and antisense HNF1 suppresses it in HepG2 cells. Deletion analysis revealed that the B element of ENII is the target region responsible for the regulation of HNF1. Sequence alignment suggested the presence of the potential HNF1 binding sites in the B element of ENII. The results of electrophoresis mobility shift assay indicated that the B2 region could specifically bind a GST-HNF1 fusion protein and could compete with binding of HNF1 to the consensus motif in rat β-fibrinogen promoter, suggesting that the major binding site of HNF1 is located in the B2 region. Our results demonstrate that HNF1 is one of the important regulatory factors for the liverspecific function of HBV and that it transregulates ENII activity via direct binding to B2.</p></div><div><p>Le facteur nucléaire hépatocytaire HNF1 transactive l'ENII/Cp (amplificateur II/promoteur du gène de capside) dans les cellules HeLa, et l'HNF1 antisens supprime cet effet dans les cellules HepG2. L'élément B de l'ENII est la région cible responsable de la régulation de l'HNF1 (sites de liaison). La région B2 peut se lier spécifiquement à la protéine de fusion GST-HNF1 et lier 1'HFN1 au motif consensus du promoteur du β-fibrinogène de rat, ce qui suggère que le site majeur de liaison de l'HNFl se trouve dans la région B2. Les présents résultats démontrent que 1'HNF1 est l'un des importants facteurs de régulation de la fonction hépatospécifique du virus de l'hépatite B et transrégule l'activité ENII en se liant directement à B2.</p></div>","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 2","pages":"Pages 99-108"},"PeriodicalIF":0.0,"publicationDate":"1998-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80085-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20522768","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 33
Amplification and detection of the terminal 3' non-coding region of hepatitis C virus isolates 丙型肝炎病毒分离株末端3′非编码区的扩增与检测
Research in virology Pub Date : 1998-03-01 Epub Date: 1999-10-26 DOI: 10.1016/S0923-2516(98)80087-3
H. Khorsi , T. Salabi , S. Castelain , O. Jaillon , P. Zawadzki , J.P. Capron , F. Eb , C. Wychowski , G. Duverlie
{"title":"Amplification and detection of the terminal 3' non-coding region of hepatitis C virus isolates","authors":"H. Khorsi ,&nbsp;T. Salabi ,&nbsp;S. Castelain ,&nbsp;O. Jaillon ,&nbsp;P. Zawadzki ,&nbsp;J.P. Capron ,&nbsp;F. Eb ,&nbsp;C. Wychowski ,&nbsp;G. Duverlie","doi":"10.1016/S0923-2516(98)80087-3","DOIUrl":"10.1016/S0923-2516(98)80087-3","url":null,"abstract":"&lt;div&gt;&lt;p&gt;A reverse transcription polymerase chain reaction (RT-PCR) assay was set up to amplify, from chronically infected patients, the recently discovered hepatitis C virus (HCV) 3′ non-coding region (3′NCR). A panel of 149 samples was tested by RT-PCR for the 3′NCR. Two detection methods of amplified products were evaluated: ethidium bromide staining on 3% agarose gel electrophoresis and DNA enzyme immunoassay (“DEIA”). Results were compared with those obtained by amplification of the 5′ noncoding region (5′NCR), i.e. the “Amplicor” HCV RNA qualitative assay. Genotype distribution of the 86 Amplicor-positive samples was subtype 1a: n = 15 (17.4%); subtype 1b: n = 32 (37.2%); subtype 2a/2c: n = 7 (8.1%); type 3: n = 25 (29%); type 4: n = 2 (2.3%); type 5: n = 1 (1.2%); not determined: n = 4 (2.3%). Sixty-three sera were HCV RNA-Amplicor-negative, 32 of which were from HCV-seronegative patients and 31 from HCV-seropositive patients. All seronegative samples were negative by both PCR methods. None of the Amplicor-negative samples from seropositive patients were positive by the 3′NCR assay. Forty-seven (54.7%) and 83 (96.5%) of the 86 Amplicor-HCV-RNA-positive samples were positive after ethidium bromide staining and by the 3′NCR assay using DEIA, respectively. The limit of detection by end-point dilution was lower with Amplicor. No difference between genotypes was detected for the 3′NCR RT-PCR, and a high degree of concordance was obtained between the Amplicor and the 3′NCR DEIA results (97.4%). Nevertheless, further studies are needed before the 3′NCR RT-PCR assay could be used instead of the 5′NCR RT-PCR for diagnostic purposes.&lt;/p&gt;&lt;/div&gt;&lt;div&gt;&lt;p&gt;Une technique de RT-PCR a été mise au point pour amplifier la région 3'-terminale non codante (3'NCR) du virus de l'hépatite C (VHC) récemment décrite. Un ensemble de 149 sérums a été testé. Deux méthodes de détection ont été évaluées, la révélation par le bromure d'éthidium sur gel d'agarose et une technique d'hybridation (≪DNA enzyme immunoassay≫ ou DEIA). Les résultats ont été comparés à une technique standardisée amplifiant la région 5′ non codante (5'NCR), le test ≪ Amplicor ≫. La répartition des génotypes des 86 sérums positifs par Amplicor est la suivante : sous-type la, n = 15; sous-type 1b, n = 32; soustype 2a/2c, n=7 ; type 3, n=25 ; type 4, n = 2; type 5, n = 1; non déterminés, n = 4. Soixante-trois sérums sont négatifs par la technique PCR Amplicor, dont 32 provenant de patients VHC&lt;sup&gt;−&lt;/sup&gt; et 31 de patients VHC&lt;sup&gt;+&lt;/sup&gt;. Tous les échantillons VHC&lt;sup&gt;−&lt;/sup&gt; sont négatifs par les techniques d'amplification des régions 3' et 5' non codantes et aucun sérum VHC&lt;sup&gt;+&lt;/sup&gt; Amplicor-négatif ne s'est révélé positif par la 3'NCR RT-PCR. Respectivement 47 (54,7 %) et 83 (96,5 %) des 86 sérums positifs par Amplicor se sont montrés positifs par révélation au bromure d'éthidium et par la méthode DEIA après amplification de la 3'NCR. La limite de détection évaluée par dilution semble également p","PeriodicalId":77352,"journal":{"name":"Research in virology","volume":"149 2","pages":"Pages 115-121"},"PeriodicalIF":0.0,"publicationDate":"1998-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S0923-2516(98)80087-3","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"20522772","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书